Practice question

Answer the question and get instant feedback.

Mediumadding ICS to LABA/LAMA (triple therapy) is conditionally recommended. Chronic azithromycin is for selected patients (e.g.ATS Clinical Practice Guideline (2020): Pharmacologic Management of COPDrespiratory medicine

A 70-year-old with COPD had two moderate exacerbations last year and blood eosinophils 350/µL. Despite LABA/LAMA he is still exacerbating. Next best step?

Educational content. Not a substitute for clinical judgement or local policy.